Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
Recruiting · NCT07372131 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients | Cytopenia, Febrile Neutropenia, Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, agranulocytosis, hematologic disorder, leukocyte disorder, leukopenia, neutropenia | Recruiting | Not applicable | 2026-09-24 | NCT07372131 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ministry of Education, Universities and Research, Italy | 1 |
| Valeria Cento | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Microbiology and Virology - IRCCS Humanitas Research Hospital | Rozzano | Italy | 1 |